Cleared Traditional

K241171 - Spine Guidance Software (Version 5.1) (FDA 510(k) Clearance)

Also includes:
Consolidated Operating Room Equipment (CORE) 2 Console CORE Q Footswitch PI Drive 2 Motors Elite Q Attachments and Cutting Accessories
Jul 2024
Decision
90d
Days
Class 2
Risk

K241171 is an FDA 510(k) clearance for the Spine Guidance Software (Version 5.1). This device is classified as a Orthopedic Stereotaxic Instrument (Class II - Special Controls, product code OLO).

Submitted by Stryker Leibinger GmbH & Co KG (Freiburg Baden-Wurttemberg, DE). The FDA issued a Cleared decision on July 25, 2024, 90 days after receiving the submission on April 26, 2024.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 882.4560. Stereotaxic Guidance During Orthopedic Surgery Procedures. Indicated For Orthopedic Joint Or Spine Surgery. Neurological Stereotaxic Instruments Are Classified Under Product Code Haw..

Submission Details

510(k) Number K241171 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 2024
Decision Date July 25, 2024
Days to Decision 90 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code OLO — Orthopedic Stereotaxic Instrument
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.4560
Definition Stereotaxic Guidance During Orthopedic Surgery Procedures. Indicated For Orthopedic Joint Or Spine Surgery. Neurological Stereotaxic Instruments Are Classified Under Product Code Haw.

Similar Devices — OLO Orthopedic Stereotaxic Instrument

All 107
TiLink-L Navigation Instruments
K253604 · SurGenTec, LLC · Mar 2026
EUROPA™ Posterior Cervical Fusion Navigated Instruments
K253444 · MiRus, LLC · Mar 2026
Q Pedicle Instruments
K260546 · K2m, Inc. · Mar 2026
TMINI® Miniature Robotic System
K260010 · THINK Surgical, Inc. · Mar 2026
Mako Total Knee Application
K260222 · Mako Surgical Corp. · Feb 2026
Valence Robotic Navigation System
K252597 · Alphatec Spine, Inc. · Feb 2026